Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023
Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…
Morgan Stanley Downgrades Agiliti to Equal-Weight, Announces $18 Price Target
Morgan Stanley analyst Drew Ranieri downgrades Agiliti (NYSE:AGTI) from Overweight to Equal-Weight and announces $18 price target.
B of A Securities Downgrades Agiliti to Neutral, Announces $19 Price Target
B of A Securities analyst Kevin Fischbeck downgrades Agiliti (NYSE:AGTI) from Buy to Neutral and announces $19 price target.
Why Agiliti Shares Are Seeing Blue Skies Today
Agiliti Inc (NYSE: AGTI) shares are trading higher by 14.01% to $19.69 Monday afternoon after it was announced on Friday the company will join the S&P SmallCap 600.
What Else?
Morgan Stanley Maintains Overweight on Agiliti, Lowers Price Target to $20
Morgan Stanley analyst Drew Ranieri maintains Agiliti (NYSE:AGTI) with a Overweight and lowers the price target from $23 to $20.
Morgan Stanley Maintains Overweight on Agiliti, Lowers Price Target to $23
Morgan Stanley analyst Drew Ranieri maintains Agiliti (NYSE:AGTI) with a Overweight and lowers the price target from $25 to $23.